402 - 625, avenue du Président-Kennedy
Montréal, Québec
Canada
H3A 3S5
Sigle : CRS
Adresse Internet : http://www.cancer-research-society.ca

  Programme(s) de recherche actif(s)

  Projet(s) actif(s)
    Assessment of a novel TLR7/8 agonist in lung cancer
    Circulating basophils and eosinophils as novel biomarkers for non-muscle invasive cancer bladder cancer
    Elucidating how ASCC3 controls the chemotherapy response in colorectal cancer
    Exploiting lipid droplet biogenesis to improve the anti-cancer potential of mTOR inhibitors.
    Impact of 2-hydroxyglutarate-induced astrocytes reactivity in low-grade glioma progression and recurrence
    Impact of vaping on lung cancer progression and response to treatment: pre-clinical investigations
    Investigating the RAS/MAPK-BRD2-ETS1 axis in cholangiocarcinoma development and progression
    New function for DEPTOR tyrosine 289 phosphorylation in glioma metabolism
    Repurposing bicalutamide to improve the response to immune checkpoint inhibition for treatment of advanced urothelial carcinoma
    Targeting the prostate cancer metabolic program for therapeutic purposes
    Targeting the sonic hedgehog medulloblastoma metabolic program for therapeutic purposes
    The effect of cannabinoid receptors on breast cancer survival